An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled.

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

By altering the mRNA structure, researchers can create stable, non-immunogenic mRNA through in vitro transcription.

These custom mRNA construct libraries enable the testing of multiple ... we are actively reviewing our current debt structure, which has a maturity on the term loan in about 3 years. As you are aware, ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

This important manuscript provides insights into the competition between Splicing Factor 1 (SF1) and Quaking (QKI) for binding at the ACUAA branch point sequence in a model intron, regulating exon ...

Announces Agreement to Acquire the DNA and RNA business of Officinae Bio, Advancing Support for Innovative Nucleic Acid R&DSAN DIEGO, Calif., ...

All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and ...

Moderna Inc.'s stock was higher but off its early highs Thursday, after the company's third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin. The ...